
Refzone S 1000mg/500mg Injection
Marketer
Ankom Laboratories
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Refzone S 1000mg/500mg Injection
Combiflox 1000mg/500mg Injection, a dual-action medication, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation, thereby curbing infection spread. Administration of Combiflox 1000mg/500mg Injection must be under a healthcare provider's guidance. Consistent adherence to the prescribed dosage schedule is crucial; completing the full course is vital, even with symptom improvement. Premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects necessitate immediate medical attention. Seek immediate medical care for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your physician of all concurrent medications prior to commencing treatment. Pregnant or lactating individuals should consult their physician before use. Alcohol consumption should be avoided due to potential additive drowsiness. While typically non-impairing, driving should be avoided if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and ample hydration promote faster recovery. Your doctor might order lab tests to monitor the medication's effects.
Primary Ingredients of Refzone S 1000mg/500mg Injection
No text provided. Please provide the text you wish to be rephrased.
Uses of Refzone S 1000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Refzone S 1000mg/500mg Injection:
This medication will be administered by your physician or their qualified assistant; self-medication is strictly prohibited.
Common Side effects of Refzone S 1000mg/500mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Refzone S 1000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Refzone S 1000mg/500mg Injection works:
Refzone S Injection (1000mg/500mg) combines the antibiotic Ceftriaxone with the beta-lactamase inhibitor Sulbactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Sulbactam counteracts bacterial resistance mechanisms, thereby augmenting Ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of alcohol and Refzone S 1000mg/500mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Refzone S, at a dosage of 1000mg/500mg, is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no harmful consequences for fetal development; nevertheless, data from human studies remain scarce.
Breast feedingCAUTION
Administering Refzone S 1000mg/500mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Refzone S 1000mg/500mg Injection can induce drowsiness, blurred vision, and dizziness. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Refzone S 1000mg/500mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
Exercise caution when administering Refzone S 1000mg/500mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Seek medical advice. Dosage alteration for Refzone S 1000mg/500mg Injection is unnecessary in patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Refzone S 1000mg/500mg Injection :
Omission of a Refzone S 1000mg/500mg Injection dose necessitates contacting your physician.
Facts to Know About Refzone S 1000mg/500mg Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Treatment | Drugs against infections |
